Alkermes plc (ALKS) Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry

Alkermes plc (NASDAQ: ALKS) FY 2026 Other Release

Newsdesk: